logo

Clinical Trial Calendar

Share
Company Name BioLineRx Ltd.
Event Name Partial results from Phase 2a study of BL-8040 in combination with KEYTRUDA
Indication Pancreatic cancer
Outcome Date 01/17/2018
Outcome positive results reported on Jan 17, 2018
Result Date Jan 2018
News
http://ir.biolinerx.com/phoenix.zhtml?c=208785&p=irol-newsArticle&ID=2326963
Return to Clinical Trial Calendar